Navigation Links
SNAP! CRACKLE! POP! Untrained Chiropractors Doing Acupuncture!
Date:4/8/2008

Insane or Just Plain Fraudulent Asks Top Acupuncture Physician

SOUTH FALLSBURG, N.Y., April 8, 2008 /PRNewswire/ -- Just when you thought it was safe to get acupuncture yet one more group of medical practitioners fights for the right to be shamelessly under qualified. This time it's chiropractors.

For licensed acupuncturists it's relatively ordinary to "cure" asthma, ADD, hot flashes, post-stroke injury, digestive problems, acne, difficult and chronic pain, shingles, autism and more says Master Acupuncturist Tom Chi, a Doctor of Acupuncture (RI) and NYS Licensed Acupuncturist.

Chi, who has practiced for 25+ years and done over 120,000 treatments, says acupuncture is the new medicine and will become the first choice for non-emergency medicine within the next 5 to 10 years.

"Real acupuncturists have a minimum of 4000 hours of training and must qualify for National Board Certification to become licensed," says Chi, "and every year we see a new group of irresponsible practitioners who want to become pretend acupuncturists and have the lobbying power to accomplish it."

This year it is New York State chiropractors that are seeking the right to practice acupuncture with just 300 hours of training. Bill #S590 incredibly would allow chiropractors to call themselves acupuncturists, a possibility that sends chills down the Licensed Acupuncturists spine!

Members of ASNY, the NYS acupuncture association say it is the power of lobbyists to promote greedy unqualified practitioners from podiatrists to chiropractors who want to follow the example of allopathic doctors who lobbied for the right to practice acupuncture with just 300 hours. "My patients who've been treated by medical doctors complain about lack of results and lack of disclosure about their incomplete training. Many consider it outright fraud," says Dr. Chi.

Chi has treated over 100 medical doctors, members of congress, even a chief medical officer of Pfizer Pha
'/>"/>

SOURCE Dr. Tom Chi
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Doing Angioplasty Long After Heart Attack Still Worth It, Analysis Shows
2. Partial Face Transplant Patient Doing Well
3. Britney and K-Fed doing it all wrong, MU family researcher says
4. Adults With Diabetes Doing Better Prevention Job
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...has been little research about the physical activi...ts are exercising and what // they are doing could...ograms for asthma patients. Doctors from the Cente...nducted a study to look at the physical activity l...
...suffering from back pain, pelvic pressure, frequen...could be to blame. Fibroids are non-cancerous // g...rom very small to the size of a cantaloupe or larg...ne fibroid embolization -- a treatment that’s beco...
...tis is a common health problem worldwide. Both ost...ain and stiffness in patients.There is no cure for...maged cartilage. // A new study could help lead do...t of arthritis. The research pinpoints the molecul...
...study finds angioplasty should be the treatment of...pital they initially go to doesn’t offer angioplas...nother facility for treatment. Research has shown ...hey are treated with angioplasty to open up the cl...
Other Medicine News:
(Date:8/27/2008)...tients in the VELCADE, melphalan and prednisone ar... well as a 30 percent complete response -, CAMBRI...e Takeda,Oncology Company today announced the publ...d, Phase III VISTA(1) trial in this week,s edition...ts showed a significant survival,benefit and a 30 ...
(Date:8/27/2008)...First Phase 3 data, from BLISS-52 trial, expected ...LISS-76, expected by fall 2009 -, ROCKVILLE, Md.,...iences, Inc. (Nasdaq: HGSI ) today announced it h...S-76, the second of two pivotal Phase 3,randomized... patients with,active systemic lupus erythematosus...
(Date:8/26/2008)...IANAPOLIS, Aug. 26 /- Semafore Pharma...national Congress on Targeted Therapies,in Cancer ...ovel,multi-targeted kinase inhibitors that demonst...l studies., A novel and proprietary molecular sca...ing allowing for the design of pan-PI3 kinase inhi...
(Date:8/26/2008)...LO PARK, Calif., Aug. 26 /-... the positive one-year follow-up data,from the CUS...e of the,peer-reviewed journal, EuroIntervention. ...tella, M.D., of University Medical Center Utrecht,...II Investigators from 13 clinical,sites across Eur...
Breaking Medicine Technology:New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Blood pressure drug telmisartan shows powerful activity against stroke 1570 1Blood pressure drug telmisartan shows powerful activity against stroke 1570 2Blood pressure drug telmisartan shows powerful activity against stroke 1570 3Ireland Cancer Center researchers advance stem cell gene therapy 1565 1Ireland Cancer Center researchers advance stem cell gene therapy 1565 2Ireland Cancer Center researchers advance stem cell gene therapy 1565 3Wind power explored off Californias coast 1563 1Wind power explored off Californias coast 1563 2Wind power explored off Californias coast 1563 3Wind power explored off Californias coast 1563 4Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 1Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 2Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 3Ceregene Presents Long term Follow up From Phase 1 Trial of CERE 120 in Parkinsons Disease 1050 4
The PachPen uses state-of-the-art waveform analysis and a probe that samples at a 65MHz rate to obtain precise readings. The PachPen stores and averages nine measurements and calculates IOP correctio
...ailable as both regular and filter tips. Sterilize...re efficient sterilization and are delivered with ...e of irradiation. Sterilized Diamond Tips are read...k Diamond Tips are wrapped in medical device quali...
300 L, Bulk Recommended for 250 and 300 L pipettes.
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio
Medicine Products: